New spinoff company uses novel method to target drugs

WINSTON-SALEM, N.C. - Buoyed by continued successes of a novel method for targeting drugs inside the body, Louis S. Kucera, Ph.D. has formed Kucera Pharmaceutical Co. as a spinoff from Wake Forest University School of Medicine and the University of North Carolina at Chapel Hill. The technique involves the coupling of compounds called phospholipids -- newly developed by Kucera and his colleagues -- with existing drugs, which markedly increases the effectiveness of those drugs against cancer and viruses, including hepatitis and HIV/AIDS. The combinations often mean that chemotherapy can be given orally rather than intravenously.

Kucera, professor of microbiology and immunology, already holds five U.S. patents and several pending patents in relation to his research, and Wake Forest and UNC have licensed those patents to Kucera Pharmaceutical, which was formally created last week, and which already has its first infusion of venture capital.

Kucera said R. H. (Russ) Read, who has more than 25 years of experience in the pharmaceutical industry, mostly in the sales and marketing of antiviral drugs, would be president and CEO of the new company. Kucera himself will be listed as senior vice president and founder and his son, Gregory L. Kucera, Ph.D., research assistant professor of internal medicine (hematology/oncology) will be secretary-treasurer. Both Kuceras will remain full-time Wake Forest faculty members.

"This technology is applicable to drug delivery not only for treatment of HIV infections but also for cancer and central nervous system diseases," said Kucera. "The technology has broad applications for developing new strategies for the treatment of human diseases. That's where the excitement comes in."

The company has been in the works for nearly two years, under the guidance of Spencer Lemons, director of Wake Forest's Office of Technology Asset Management. Lemons helped in finding leadership for the company, wo

Contact: Robert Conn or Jim Steele
Wake Forest University Baptist Medical Center

Page: 1 2

Related biology news :

1. Rutgers spinoff success yields $4.3 million payback to university
2. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
3. Light Biology, a biotech company based on UT Southwestern technology, bought by NimbleGen Systems
4. Worlds leading mad cow diagnostic company, responds to USDAs additional BSE protection measures
5. First company founded on UCF biotechnology formed
6. Purdue Research Park company makes melt-in-your-mouth meds
7. Convergent technologies: Is your company ready for the future?
8. New Knox company has big plans for ORNL technology
9. ViaCell Inc., the worlds largest umbilical cord blood research and banking company comments on Bush administrations decision
10. Intercure Scientific Advisory Board convenes to review companys resperate medical device for hypertension
11. "All my friends dream of artificial limbs": US, Russian nuclear labs work with prosthetics company to develop replacement knee

Post Your Comments:

(Date:6/25/2020)... ... June 24, 2020 , ... eClinical ... clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... in hospitalized patients with severe COVID-19. This is the first study of an ...
(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
(Date:6/19/2020)... (PRWEB) , ... June 16, 2020 , ... The director ... is betting that if the stem cell medicine and pharmaceutical industries have easier access ... practice. So, starting July 5 of this year, Independence Day weekend in the ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... , ... August 13, 2020 , ... True Terpenes ... creation of its Scientific Advisory Board (SAB) to research the medical potential of terpenes ... be enhanced when combined with terpenes. The board is focused on expanding the recently ...
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 29, 2020 , ... R3 ... joint injections for only $3950. With 50 million stem cells total, patients may choose ... stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
Breaking Biology Technology:
Cached News: